| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ... Nature genetics 45 (6), 613-620, 2013 | 863 | 2013 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 594 | 2021 |
| The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis PL Molyneaux, MJ Cox, SAG Willis-Owen, P Mallia, KE Russell, ... American journal of respiratory and critical care medicine 190 (8), 906-913, 2014 | 552 | 2014 |
| Persistent post–COVID-19 interstitial lung disease. An observational study of corticosteroid treatment KJ Myall, B Mukherjee, AM Castanheira, JL Lam, G Benedetti, SM Mak, ... Annals of the American Thoracic Society 18 (5), 799-806, 2021 | 512 | 2021 |
| Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease PL Molyneaux, P Mallia, MJ Cox, J Footitt, SAG Willis-Owen, D Homola, ... American journal of respiratory and critical care medicine 188 (10), 1224-1231, 2013 | 445 | 2013 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 382 | 2022 |
| Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ... The lancet Respiratory medicine 3 (6), 462-472, 2015 | 332 | 2015 |
| PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Science translational medicine 10 (460), eaar8356, 2018 | 310 | 2018 |
| Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities PM George, P Spagnolo, M Kreuter, G Altinisik, M Bonifazi, FJ Martinez, ... The lancet Respiratory medicine 8 (9), 925-934, 2020 | 305 | 2020 |
| Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study RJ Allen, J Porte, R Braybrooke, C Flores, TE Fingerlin, JM Oldham, ... The Lancet respiratory medicine 5 (11), 869-880, 2017 | 300 | 2017 |
| Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis RJ Allen, B Guillen-Guio, JM Oldham, SF Ma, A Dressen, ML Paynton, ... American journal of respiratory and critical care medicine 201 (5), 564-574, 2020 | 295 | 2020 |
| The microbiome in respiratory medicine: current challenges and future perspectives R Faner, O Sibila, A Agustí, E Bernasconi, JD Chalmers, GB Huffnagle, ... European Respiratory Journal 49 (4), 2017 | 265 | 2017 |
| An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study TM Maher, E Oballa, JK Simpson, J Porte, A Habgood, WA Fahy, A Flynn, ... The Lancet Respiratory Medicine 5 (12), 946-955, 2017 | 263 | 2017 |
| Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study N Navani, PL Molyneaux, RA Breen, DW Connell, A Jepson, M Nankivell, ... Thorax 66 (10), 889-893, 2011 | 256 | 2011 |
| Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis CJ Stock, H Sato, C Fonseca, WAS Banya, PL Molyneaux, H Adamali, ... Thorax, 2013 | 246 | 2013 |
| Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study TM Drake, AB Docherty, EM Harrison, JK Quint, H Adamali, S Agnew, ... American journal of respiratory and critical care medicine 202 (12), 1656-1665, 2020 | 240 | 2020 |
| Lung microbiology and exacerbations in COPD V Beasley, PV Joshi, A Singanayagam, PL Molyneaux, SL Johnston, ... International journal of chronic obstructive pulmonary disease, 555-569, 2012 | 231 | 2012 |
| Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial D Visca, L Mori, V Tsipouri, S Fleming, A Firouzi, M Bonini, MJ Pavitt, ... The Lancet Respiratory Medicine 6 (10), 759-770, 2018 | 210 | 2018 |
| Host–microbial interactions in idiopathic pulmonary fibrosis PL Molyneaux, SAG Willis-Owen, MJ Cox, P James, S Cowman, ... American journal of respiratory and critical care medicine 195 (12), 1640-1650, 2017 | 208 | 2017 |
| The role of infection in the pathogenesis of idiopathic pulmonary fibrosis PL Molyneaux, TM Maher European Respiratory Review 22 (129), 376-381, 2013 | 205 | 2013 |
Toby Michael MaherKeck Medicine of University of Southern CaliforniaVahvistettu sähköpostiosoite verkkotunnuksessa usc.edu